Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dafna Gladman

Showing results (71-80 of 86) with videos related to

Pageof 9
Sort By:
European Journal of Human Genetics : EJHG|September 4, 2014
Fine mapping of eight psoriasis susceptibility lociSayantan Das, Philip E Stuart, Jun Ding, et al.
Journal of the American Academy of Dermatology|November 6, 2007
From the Medical Board of the National Psoriasis Foundation: monitoring and vaccinations in patients treated with biologics for psoriasisMark Lebwohl, Jerry Bagel, Joel M Gelfand, et al.
Oncology|October 11, 2013
Non-lymphoma hematological malignancies in systemic lupus erythematosusMary Lu, Sasha Bernatsky, Rosalind Ramsey-Goldman, et al.
Journal of the American Academy of Dermatology|March 18, 2024
Full Guidelines-From the Medical Board of the National Psoriasis Foundation: Perioperative management of systemic immunomodulatory agents in patients with psoriasis and psoriatic arthritisWarren A James, Angela L Rosenberg, Jashin J Wu, et al.
Annals of the Rheumatic Diseases|September 11, 2016
International patient and physician consensus on a psoriatic arthritis core outcome set for clinical trialsAna-Maria Orbai, Maarten de Wit, Philip Mease, et al.
Arthritis Care & Research|January 29, 2014
25-hydroxyvitamin D and cardiovascular disease in patients with systemic lupus erythematosus: data from a large international inception cohortApinya Lertratanakul, Peggy Wu, Alan Dyer, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|December 2, 2017
Group for Research and Assessment of Psoriasis and Psoriatic Arthritis/Outcome Measures in Rheumatology Consensus-Based Recommendations and Research Agenda for Use of Composite Measures and Treatment Targets in Psoriatic ArthritisLaura C Coates, Oliver FitzGerald, Joseph F Merola, et al.
Journal of the American Academy of Dermatology|January 10, 2021
National Psoriasis Foundation COVID-19 Task Force guidance for management of psoriatic disease during the pandemic: Version 2-Advances in psoriatic disease management, COVID-19 vaccines, and COVID-19 treatmentsJoel M Gelfand, April W Armstrong, Stacie Bell, et al.
Journal of the American Academy of Dermatology|September 6, 2020
National Psoriasis Foundation COVID-19 Task Force Guidance for Management of Psoriatic Disease During the Pandemic: Version 1Joel M Gelfand, April W Armstrong, Stacie Bell, et al.
American Journal of Human Genetics|April 24, 2012
Rare and common variants in CARD14, encoding an epidermal regulator of NF-kappaB, in psoriasisCatherine T Jordan, Li Cao, Elisha D O Roberson, et al.
Pageof 9

Showing results (71-80 of 86) with videos related to

Sort By:
Pageof 9
European Journal of Human Genetics : EJHG|September 4, 2014
Fine mapping of eight psoriasis susceptibility lociSayantan Das, Philip E Stuart, Jun Ding, et al.
Journal of the American Academy of Dermatology|November 6, 2007
From the Medical Board of the National Psoriasis Foundation: monitoring and vaccinations in patients treated with biologics for psoriasisMark Lebwohl, Jerry Bagel, Joel M Gelfand, et al.
Oncology|October 11, 2013
Non-lymphoma hematological malignancies in systemic lupus erythematosusMary Lu, Sasha Bernatsky, Rosalind Ramsey-Goldman, et al.
Journal of the American Academy of Dermatology|March 18, 2024
Full Guidelines-From the Medical Board of the National Psoriasis Foundation: Perioperative management of systemic immunomodulatory agents in patients with psoriasis and psoriatic arthritisWarren A James, Angela L Rosenberg, Jashin J Wu, et al.
Annals of the Rheumatic Diseases|September 11, 2016
International patient and physician consensus on a psoriatic arthritis core outcome set for clinical trialsAna-Maria Orbai, Maarten de Wit, Philip Mease, et al.
Arthritis Care & Research|January 29, 2014
25-hydroxyvitamin D and cardiovascular disease in patients with systemic lupus erythematosus: data from a large international inception cohortApinya Lertratanakul, Peggy Wu, Alan Dyer, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|December 2, 2017
Group for Research and Assessment of Psoriasis and Psoriatic Arthritis/Outcome Measures in Rheumatology Consensus-Based Recommendations and Research Agenda for Use of Composite Measures and Treatment Targets in Psoriatic ArthritisLaura C Coates, Oliver FitzGerald, Joseph F Merola, et al.
Journal of the American Academy of Dermatology|January 10, 2021
National Psoriasis Foundation COVID-19 Task Force guidance for management of psoriatic disease during the pandemic: Version 2-Advances in psoriatic disease management, COVID-19 vaccines, and COVID-19 treatmentsJoel M Gelfand, April W Armstrong, Stacie Bell, et al.
Journal of the American Academy of Dermatology|September 6, 2020
National Psoriasis Foundation COVID-19 Task Force Guidance for Management of Psoriatic Disease During the Pandemic: Version 1Joel M Gelfand, April W Armstrong, Stacie Bell, et al.
American Journal of Human Genetics|April 24, 2012
Rare and common variants in CARD14, encoding an epidermal regulator of NF-kappaB, in psoriasisCatherine T Jordan, Li Cao, Elisha D O Roberson, et al.
Pageof 9